Bétrixaban (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bétrixaban" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
57th place
4th place
1,389th place
508th place
low place
low place
447th place
1,409th place

doi.org (Global: 2nd place; French: 3rd place)

dx.doi.org

  • (en) Jürgen Koscielny, Christoph Rosenthal et Christian von Heymann, « Update on Direct Oral AntiCoagulants (DOACs) », Hamostaseologie, vol. 37, no 4,‎ , p. 267–75. (ISSN 2567-5761, PMID 29582929, DOI 10.5482/HAMO-16-10-0041)
  • (en) Turpie AGG, Bauer KA, Davidson BL, Expert Study Group et al., « A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) », Thromb Haemost, vol. 101, no 1,‎ , p. 68-76. (PMID 19132191, DOI 10.1160/TH08-07-0460)
  • (en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20,‎ , p. 1498-505. (PMID 23487517, PMCID PMC3659305, DOI 10.1093/eurheartj/eht039, lire en ligne [html])
  • (en) Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber et Russell D. Hull, « Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients », N Engl J Med, vol. 375, no 6,‎ 08 11, 2016, p. 534–44. (ISSN 1533-4406, PMID 27232649, DOI 10.1056/NEJMoa1601747)

fda.gov (Global: 447th place; French: 1,409th place)

accessdata.fda.gov

issn.org (Global: 57th place; French: 4th place)

portal.issn.org

nih.gov (Global: 4th place; French: 12th place)

ncbi.nlm.nih.gov

  • (en) Jürgen Koscielny, Christoph Rosenthal et Christian von Heymann, « Update on Direct Oral AntiCoagulants (DOACs) », Hamostaseologie, vol. 37, no 4,‎ , p. 267–75. (ISSN 2567-5761, PMID 29582929, DOI 10.5482/HAMO-16-10-0041)
  • (en) Turpie AGG, Bauer KA, Davidson BL, Expert Study Group et al., « A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) », Thromb Haemost, vol. 101, no 1,‎ , p. 68-76. (PMID 19132191, DOI 10.1160/TH08-07-0460)
  • (en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20,‎ , p. 1498-505. (PMID 23487517, PMCID PMC3659305, DOI 10.1093/eurheartj/eht039, lire en ligne [html])
  • (en) Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber et Russell D. Hull, « Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients », N Engl J Med, vol. 375, no 6,‎ 08 11, 2016, p. 534–44. (ISSN 1533-4406, PMID 27232649, DOI 10.1056/NEJMoa1601747)

oxfordjournals.org (Global: 1,389th place; French: 508th place)

eurheartj.oxfordjournals.org

  • (en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20,‎ , p. 1498-505. (PMID 23487517, PMCID PMC3659305, DOI 10.1093/eurheartj/eht039, lire en ligne [html])

venoustimes.net (Global: low place; French: low place)